Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × temsirolimus × 30 days × Clear all

Phase

Status

Sponsor Class

NIH 3 OTHER 2 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1

Interventions

Specimen Handling 23 Magnetic Resonance Spectroscopy 20 Cyclophosphamide 12 Vincristine 11 Radiation 11 Biopsy 11 Radiotherapy 9 Cisplatin 9 Carboplatin 8 Leucovorin 7 Etoposide 7 Cytarabine 7 dehydroftorafur 6 Radiotherapy, Intensity-Modulated 6 Platinum 6 Irinotecan 6 Fluorouracil 6 Doxorubicin 6 1,2-diaminocyclohexaneplatinum II citrate 6 Taxes 5 Stem Cell Transplantation 5 Standard of Care 5 Spinal Puncture 5 Practice Guidelines as Topic 5 Methotrexate 5 Ifosfamide 5 Dexamethasone 5 merphos 4 daratumumab 4 X-Rays 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03297606 2026-03-04

CAPTUR

Canadian Cancer Trials Group

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡